Titan Medical Inc. Announces Appointment of Senior Vice President of Business Development
TORONTO, ONTARIO -- (MARKET WIRE) -- 06/02/10 -- Titan Medical Inc. ("the Company") (TSX VENTURE: TMD) is pleased to announce the appointment of Mr. Joseph Talarico as the Senior Vice President, Business Development, a newly created position, for the Company. Mr. Talarico has been involved in the surgical medical device industry for over seven years, most notably with Intuitive Surgical, Inc. for five years.
From 2004 to 2009, Mr. Talarico held various positions with Intuitive Surgical, Inc., including Area Training Director (East Coast), Clinical Sales Manager, Area Sales Manager and Clinical Sales Representative. From 2003 to 2004, Mr. Talarico served as Territory Manager for U.S. Surgical Corporation training and selling laparoscopic equipment to general, thoracic, urology, and GYN surgeons in Upstate New York. Mr. Talarico holds a J.D., Law from Syracuse University College of Law and a B.S., Political Science and Sociology from University of Rochester.
Craig Leon, Chief Executive Officer of Titan Medical Inc., commented as follows:
"As Titan Medical moves towards commercialization with Amadeus, we are very pleased to have Joe as part of the management team where he will bring a wealth of robotic surgical experience to the Company in the areas of business development, sales management, hospital recruiting and surgeon training."
About Titan Medical Inc.
Titan Medical Inc. is a Canadian public company (TSX VENTURE: TMD) focused on the development and commercialization of robotic surgical technologies. The Company is currently developing Amadeus, a next generation 4-armed robotic surgical system, with the objective of enabling surgeons to remotely manipulate surgical instruments. Robotic surgery has developed over the past 10 years into a proven and growing method of treatment. The global robotic surgical market size is currently estimated to be over $1 billion with potential for placement of 6,000 robotic surgical systems. The Company is researching and developing innovative technologies to empower surgeons to use robots in the operating room of the future. For more information, visit the Company's website at www.titanmedicalinc.com.
Forward Looking Statements
This news release contains "forward-looking statements" which reflect the current expectations of management of the Company's future growth, results of operations, performance and business prospects and opportunities. Wherever possible, words such as "may", "would", "could", "will", "anticipate", "believe", "plan", "expect", "intend", "estimate" and similar expressions have been used to identify these forward-looking statements. These statements reflect management's current beliefs with respect to future events and are based on information currently available to management. Forward-looking statements involve significant risks, uncertainties and assumptions. Many factors could cause the Company's actual results, performance or achievements to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements, including, without limitation, those listed in the "Risk Factors" section of the Company's Annual Information Form dated April 9, 2010 (which may be viewed at www.sedar.com). Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward looking statements prove incorrect, actual results, performance or achievements may vary materially from those expressed or implied by the forward-looking statements contained in this news release. These factors should be considered carefully and prospective investors should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in the news release are based upon what management currently believes to be reasonable assumptions, the Company cannot assure prospective investors that actual results, performance or achievements will be consistent with these forward-looking statements.
The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.
Contacts: Titan Medical Inc. Craig Leon Chief Executive Officer (416) 548-7522 (ext. 151) www.titanmedicalinc.com
Released June 2, 2010